- Product Details
Keywords
- Fulvestrant
- Fulvestrant
- Fulvestrant
Quick Details
- ProName: Fulvestrant
- CasNo: 129453-61-8
- Molecular Formula: C32H47F5O3S
- Appearance: white powder
- Application: Fulvestrant (trade name Faslodex, by A...
- Port: shanghai
- ProductionCapacity: Metric Ton/Day
- Purity: more than 97%
- LimitNum: 0 Metric Ton
- Grade: Pharma Grade
Superiority
Fulvestrant is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It is a complete estrogen receptor antagonist with no agonist effects, which in addition, accelerates the proteasomal degradation of the estrogen receptor. The drug has poor oral bioavailability, and is administered monthly via intramuscular injection.
Details
Fulvestrant is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It is a complete estrogen receptor antagonist with no agonist effects, which in addition, accelerates the proteasomal degradation of the estrogen receptor. The drug has poor oral bioavailability, and is administered monthly via intramuscular injection.
USP grade.